ENDRA LIFE SCIENCES INC. Diluted Shares Outstanding (Weighted Average)
ENDRA LIFE SCIENCES INC. (NDRA) reported Diluted Shares Outstanding (Weighted Average) of 2.48 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 2.48M shares, a 245.17% increase year-over-year.
- ENDRA LIFE SCIENCES INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.20M shares, a 115.14% increase year-over-year.
- ENDRA LIFE SCIENCES INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 1.11M shares, a 105.77% increase year-over-year.
- ENDRA LIFE SCIENCES INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 761.22K shares, a 208.42% increase year-over-year.
- ENDRA LIFE SCIENCES INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 787.02K shares, a 289.41% increase from fiscal 2024.
- ENDRA LIFE SCIENCES INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 202.11K shares, a 5458.47% increase from fiscal 2023.
- ENDRA LIFE SCIENCES INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 3.64K shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 2.48M shares 10-Q · filed 2026-08-14 | 1.26M shares 10-Q · filed 2026-08-14 | 1.60M shares derived: average of 3 quarters · filed 2026-08-14 | 1.39M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 1.20M shares 10-Q · filed 2026-05-15 | 1.16M shares derived: average of 2 quarters · filed 2026-05-15 | 1.02M shares derived: average of 3 quarters · filed 2026-05-15 | 947.09K shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 1.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 935.83K shares derived: average of 2 quarters · filed 2026-03-31 | 862.92K shares derived: average of 3 quarters · filed 2026-08-14 | 787.02K shares 10-K · filed 2026-03-31 |
| 2025-09-30 | 761.22K shares 10-Q · filed 2025-11-14 | 739.16K shares derived: average of 2 quarters · filed 2026-08-14 | 679.21K shares 10-Q · filed 2025-11-14 | 643.89K shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 717.11K shares 10-Q · filed 2026-08-14 | 637.36K shares 10-Q · filed 2026-08-14 | 604.78K shares derived: average of 3 quarters · filed 2026-08-14 | 515.29K shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 557.58K shares 10-Q · filed 2026-05-15 | 548.62K shares derived: average of 2 quarters · filed 2026-05-15 | 448.02K shares derived: average of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | 539.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 393.23K shares derived: average of 2 quarters · filed 2026-03-31 | 202.11K shares 10-K · filed 2026-03-31 | |
| 2024-09-30 | 246.82K shares 10-Q · filed 2025-11-14 | 89.59K shares 10-Q · filed 2025-11-14 | ||
| 2023-12-31 | 3.64K shares 10-K/A · filed 2025-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |